Glymepiride (amaril): Clinical pharmacology and compliance in diabetes mellitus
https://doi.org/10.14341/probl11536
Abstract
The article reviews an action of glimepiride (amaryl), its clinical pharmacology and compliance in diabetes mellitus.
About the Author
О. I. KarpovInstitute of Pharmacology, Pavlov State Medical University of St. Petersburg
Russian Federation
References
1. Карпов О. II. // Антибиотики и химиотер. - 1999. - № 8. - С. 37-45.
2. Abbink Е. J., Tack С. J., Pickers Р. et al. // Abstracts of 36-th Annual Meeting of EASD. - Jerusalem, 2000. - N 155.
3. Browne D. L., Avery L., Turner В. C. et al. // Diabet. Med. - 2000. - Voi. 17, N 7. - P. 528-531.
4. Curran M., Cameron A. // PharmacoEconomics and Out comes. News. - 1999. - N 239.
5. Diabetes 1996 Vital Statistics. - Alexandria, 1996.
6. Drug Interactions / Ed. I. H. Stockley. - 3-rd Ed. – Oxford. - P. 553.
7. Goldberg R. B., Holvey S. M. // Diabetes Care. - 1996. - Vol. 19, N 8. - P. 849-857.
8. Gomis R., Raptis S. A., Ravella R. // Endocrine. - 2000. - Vol. 13, N 1. - P. 117-121.
9. Gribble F. M., Tucker S. J., Sieno S., Ashcroft F. M. 11 Diabetes. - 1998. - Vol. 47. - P. 1412-1418.
10. Hariharan R. S., Nihalani K. D., Sahay В. K. et al. // J. Gen. Med. - 1999. - Vol. 11, N 3. - P. 69-74.
11. Holstein A., Plaschke A., Egberts E.-H. // Abstracts of 36-th Annual Meeting of EASD. - Jerusalem, 2000. - N 157.
12. Kamel N. M., Badawy Y. A., el-Zeiny N. A., Merdan 1. A. // East Mediterr. Hlth J. - 2000. - Vol. 5, N 5. - P. 967-973.
13. Kramer W., Muller G., Gibig F. et al. // Biochim. Biophys. Ac ta. - 1994. - Vol. 1191, N 2. - P. 278-290.
14. Lantion-Ang L. С. I I Diabetes Res. Clin. Pract. - 2000. - Vol. 50. - Suppl. 2. - P. S29-S34.
15. Liebl A., Goerts A., Henkel B., Spannheimer A. // Fortschr. Med. - 2000. - Bd 142, N 23. - S. 39-42.
16. Lober R., Steiner-Drapalik S., Krause B., Luger A. // Jatros Di abet. Metab. - 1999. - Special Ed. - Vol. 2.
17. Nattrass M., Bailey C. J. // Baillieres Clin. Endocrinol. Metab. - 1999. - Vol. 13, N 2. - P. 309-329.
18. O’Brien R. C., Luo M., Balazs N., Mercuri J. // J. Diabet. Compl. - 2000. - Vol. 14, N 4. - P. 201-206.
19. Ochi H., Ikeda T. // Nephron. - 1999. - Vol. 81. - P. 67- 71.
20. Rosenkranz B. // Hormone Metab. Res. - 1996. - Vol. 28, N 9. - P. 434-439.
21. Rosenkranz B., Profozic V., Metelko Z. et al. // Diabetologia. - 1996. - Vol. 39, N 12. - P. 1617-1624.
22. Rosenstock J., Samols E., Muchmore D. B. // Diabetes Care. - 1996. - Vol. 19. N 11. - P. 1194-1196.
23. Samraj G. P. N., Quillen D. M., Kuritzki L. // Hosp. Pract. - Vol. 15. - P. 129-137.
24. Schade D. S., Jovanovic L., Schneider J. // J. Clin. Pharmacol. - 1998. - Vol. 38, N 7. - P. 636-641.
25. Schmidt A. M., Stern D. M. // Circulat. Res. - 2000. - Vol. 87, N 9. - P. 722-725.
26. de Smet P. A., Fischer H. R. // Ned. T. Geneesk. - 2000. - Vol. 144. - P. 1206-1209.
27. Sulfonylharnstoff-Therapie ohne Gewichtszunahme // Jatros Diabet. Stoffwechsel. - 1999. - N 3. - P. 1-4.
28. Tian Y. A., Johnson G., Ashcroft S. J. // Diabetes. - 1998. - Vol. 47, N 11. - P. 1722-1726.
29. Wallace T. M., Matthews D. R. // Quart. J. Med. - 2000. - Vol. 93, N 6. - P. 369-374.
30. Weyere C., Pratley R. E., Snitker S. et al. // Hypertension. - Vol. 36, N 4. - P. 531-536.
Review
For citations:
Karpov О.I. Glymepiride (amaril): Clinical pharmacology and compliance in diabetes mellitus. Problems of Endocrinology. 2001;47(3):41-44. (In Russ.) https://doi.org/10.14341/probl11536

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).